Protective effects of fenofibrate against acute lung injury induced by intestinal ischemia/reperfusion in mice

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Zhu, Qiankun ^a   He, Guizhen ^a   Wang, Jie ^a   Wang, Yukang ^a   Chen, Wei ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FENOFIBRATE; NONSTEROID ANTIINFLAMMATORY AGENT;

ACUTE LUNG INJURY; ANIMAL; C57BL MOUSE; COMPLICATION; DISEASE MODEL; INJURIES; INTESTINE; MALE; MOUSE; PATHOLOGY; REPERFUSION INJURY; VASCULARIZATION;

ACUTE LUNG INJURY; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DISEASE MODELS, ANIMAL; FENOFIBRATE; INTESTINES; MALE; MICE; MICE, INBRED C57BL; REPERFUSION INJURY;

EID: 84959167361     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep22044     Document Type: Article

References (33)

1. Rubenfeld, G. D. et al. Incidence and outcomes of acute lung injury. N Engl J Med. 353, 1685-1693 (2005).
2. Matuschak, G. M. & Lechner, A. J. Acute lung injury and the acute respiratory distress syndrome: Pathophysiology and treatment. Mo Med. 107, 252-258 (2010).
3. Mabbott, N. A. et al. Aging and the mucosal immune system in the intestine. BIOGERONTOLOGY. 16, 133-145 (2015).
4. Moraes, L. B. et al. Gut ischemia/reperfusion induced acute lung injury is an alveolar macrophage dependent event. J Trauma. 64, 1196-1200, 1200-1201 (2008).
5. Zhao, W. et al. The interaction between oxidative stress and mast cell activation plays a role in acute lung injuries induced by intestinal ischemia/reperfusion. J SURG RES. 187, 542-552 (2014).
6. Kaszaki, J., Wolfard, A., Szalay, L. & Boros, M. Pathophysiology of ischemia/reperfusion injury. Transplant Proc. 38, 826-828 (2006).
7. Guay, D. R. Update on fenofibrate. Cardiovasc Drug Rev. 20, 281-302 (2002).
8. Agouridis, A. P. et al. The effects of rosuvastatin alone or in combination with fenofibrate or omega 3 fatty acids on inflammation and oxidative stress in patients with mixed dyslipidemia. Expert Opin Pharmacother. 12, 2605-2611 (2011).
9. Otsuki, M., Goya, K. & Kasayama, S. Vascular endothelium as a target of beraprost sodium and fenofibrate for antiatherosclerotic therapy in type 2 diabetes mellitus. Vasc Health Risk Manag. 1, 209-215 (2005).
10. Bhalodia, Y., Sheth, N., Vaghasiya, J. & Jivani, N. Role of fenofibrate alone and in combination with telmisartan on renal ischemia/reperfusion injury. Ren Fail. 32, 1088-1094 (2010).
11. Patel, N. S. et al. Peroxisome proliferator-activated receptor-alpha contributes to the resolution of inflammation after renal ischemia/reperfusion injury. J PHARMACOL EXP THER. 328, 635-643 (2009).
12. Boshra, V. & Moustafa, A. M. Effect of preischemic treatment with fenofibrate, a peroxisome proliferator-activated receptor-alpha ligand, on hepatic ischemia/reperfusion injury in rats. J MOL HISTOL. 42, 113-122 (2011).
13. Gele, P. et al. Recovery of brain biomarkers following peroxisome proliferator-activated receptor agonist neuroprotective treatment before ischemic stroke. PROTEOME SCI. 12, 24 (2014).
14. Ouk, T. et al. Effects of the PPAR-alpha agonist fenofibrate on acute and short-term consequences of brain ischemia. J Cereb Blood Flow Metab. 34, 542-551 (2014).
15. Sugga, G. S., Khan, M. U. & Khanam, R. Protective role of fibrates in cardiac ischemia/reperfusion. J Adv Pharm Technol Res. 3, 188-192 (2012).
16. Ware, L. B. Pathophysiology of acute lung injury and the acute respiratory distress syndrome. Semin Respir Crit Care Med. 27, 337-349 (2006).
17. Chiu, C. J., McArdle, A. H., Brown, R., Scott, H. J. & Gurd, F. N. Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic and metabolic reappraisal. Arch Surg. 101, 478-483 (1970).
18. Lane, J. S. et al. Interleukin-10 reduces the systemic inflammatory response in a murine model of intestinal ischemia/reperfusion. SURGERY. 122, 288-294 (1997).
19. Gu, J. & Korteweg, C. Pathology and pathogenesis of severe acute respiratory syndrome. AM J PATHOL. 170, 1136-1147 (2007).
20. Suzuki, T. et al. The novel NF-kappaB inhibitor, dehydroxymethylepoxyquinomicin, prevents local and remote organ injury following intestinal ischemia/reperfusion in rats. J SURG RES. 149, 69-75 (2008).
21. Jia, Z. et al. HMGB1 is Involved in the Protective Effect of the PPAR alpha Agonist Fenofibrate against Cardiac Hypertrophy. PPAR RES. 2014, 541394 (2014).
22. Bhatia, M. & Moochhala, S. Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. J PATHOL. 202, 145-156 (2004).
23. Lin, Z. L. et al. Protective effects of terminal ileostomy against bacterial translocation in a rat model of intestinal ischemia/reperfusion injury. World J Gastroenterol. 20, 17905-17913 (2014).
24. Zhang, F. et al. Protective effects of icariin-mediated SIRT1/FOXO3 signaling pathway on intestinal ischemia/reperfusion-induced acute lung injury. MOL MED REP. 11, 269-276 (2015).
25. de Lima, F. M. et al. Dual Effect of low-level laser therapy (LLLT) on the acute lung inflammation induced by intestinal ischemia and reperfusion: Action on anti- and pro-inflammatory cytokines. Lasers Surg Med. 43, 410-420 (2011).
26. Gropper, M. A. & Wiener-Kronish, J. The epithelium in acute lung injury/acute respiratory distress syndrome. CURR OPIN CRIT CARE. 14, 11-15 (2008).
27. Maniatis, N. A. & Orfanos, S. E. The endothelium in acute lung injury/acute respiratory distress syndrome. CURR OPIN CRIT CARE. 14, 22-30 (2008).
28. Chen, G. et al. The canonical Notch signaling was involved in the regulation of intestinal epithelial cells apoptosis after intestinal ischemia/reperfusion injury. INT J MOL SCI. 15, 7883-7896 (2014).
29. Breithaupt-Faloppa, A. C. et al. Protective effect of estradiol on acute lung inflammation induced by an intestinal ischemic insult is dependent on nitric oxide. SHOCK. 40, 203-209 (2013).
30. Ding, R., Han, J., Tian, Y., Guo, R. & Ma, X. Sphingosine-1-phosphate attenuates lung injury induced by intestinal ischemia/reperfusion in mice: Role of inducible nitric-oxide synthase. INFLAMMATION. 35, 158-166 (2012)
31. Pande, D. et al. NF-kappaB p65 subunit DNA-binding activity: Association with depleted antioxidant levels in breast carcinoma patients. CELL BIOCHEM BIOPHYS. 67, 1275-1281 (2013).
32. Lentsch, A. B., Kato, A., Yoshidome, H., McMasters, K. M. & Edwards, M. J. Inflammatory mechanisms and therapeutic strategies for warm hepatic ischemia/reperfusion injury. HEPATOLOGY. 32, 169-173 (2000).
33. Malhi, H. & Gores, G. J. Cellular and molecular mechanisms of liver injury. GASTROENTEROLOGY. 134, 1641-1654 (2008)